Feasibility and Acceptability of Metacognitive Training for Eating Disorders in Adolescents With Anorexia Nervosa
Feasibility and Acceptability of Metacognitive Training for Eating Disorders (MCT-ED) in Adolescents With Anorexia Nervosa
University of Évora
14 participants
Mar 2, 2026
INTERVENTIONAL
Conditions
Summary
This study aims to assess the feasibility and acceptability of Metacognitive Training for Eating Disorders (MCT-ED) in adolescents with anorexia nervosa and atypical anorexia nervosa.
Eligibility
Inclusion Criteria4
- Adolescents aged 13 to 19 years;
- Diagnosis of Anorexia Nervosa or Atypical Anorexia Nervosa; confirmed by the treating child and adolescent psychiatrist according to DSM-5-TR or ICD-11 criteria;
- Currently followed in an Eating Disorder Outpatient Consultation;
- Fluent in Portuguese.
Exclusion Criteria4
- Acute suicidal ideation or behaviour requiring immediate clinical intervention;
- Imminent risk of hospitalization due to clinical deterioration;
- Current diagnosis of psychotic disorder, bipolar disorder, or substance dependence;
- Any clinical condition that, in the judgment of the treating clinician, would make participation in a videoconference-based intervention inappropriate.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The intervention consists of six modules delivered across six synchronous sessions, each lasting up to 50 minutes, over a six-week period, and conducted by a mental health specialist nurse. The intervention includes one thinking styles module, two cognitive flexibility modules, two perfectionism modules, and one concluding summary module. At the beginning of each session, exercises completed at home between sessions are reviewed. All sessions are conducted individually via a video-conferencing platform, with materials presented using Microsoft PowerPoint®. Each module incorporates psychoeducational content, interactive exercises, videos, and guided reflection activities.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07435818